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Revision in the first steps of the biosynthesis of
the red antibiotic prodigiosin: use of a synthetic
thioester to validate a new intermediate†
Maxime Couturier,a Hiral D. Bhalara,a Rita E. Monson,b George P. C. Salmondb and
Finian J. Leeper *a
A biosynthetic pathway for the red-antibiotic, prodigiosin, was proposed over a decade ago but not all
the suggested intermediates could be detected experimentally. Here we show that a thioester that was
not originally included in the pathway is an intermediate. In addition, the enzyme PigE was originally
described as a transaminase but we present evidence that it also catalyses the reduction of the thioester
intermediate to its aldehyde substrate.
Introduction
Prodigiosin 11 is a tripyrrolic natural product produced by a
wide range of bacteria.1 It originally caught researchers’ attention
because of its bright red colour, but its various biological activities
have renewed interest in this molecule in recent decades.2
The biosynthetic pathway to prodigiosin was established by
Williamson et al. via cross-feeding experiments of various
knock-out mutants of Serratia ATCC sp.39006 (S39006).3 They
showed that prodigiosin resulted from a bifurcated pathway
(Fig. 1) with the independent synthesis of monopyrrole 2-
methyl-3-amylpyrrole (MAP) 7 and bipyrrole 4-methoxy-2,20-
bipyrrole-5-carbaldehyde (MBC) 9 before a final condensation
step catalysed by the enzyme PigC.
MBC is an intermediate in the biosynthesis of other prodigi-
nines, natural products which share the tripyrrolic structure of
prodigiosin 11. In particular, the enzymes involved in the
biosynthesis of MBC in Streptomyces coelicolor A(3) have been
well characterised.4 The biosynthesis of MAP, on the other hand,
is specific to the formation of prodigiosin 11. 2-Octenal 1 was
originally proposed to be the starting point of the pathway.3
Addition of an acetyl group from pyruvate by PigD was proposed
to form 3-acetyloctanal 4, which then underwent a transamina-
tion catalysed by PigE,5 leading to amino ketone 5 which
spontaneously cyclises to form dihydroMAP (H2MAP) 6. H2MAP
is then oxidised to MAP 7 by PigB.6
However, Dresen et al. showed that, when presented with an
aldehyde such as 2-octenal 1, PigD catalysed the direct addition
of the acetyl group onto the aldehyde carbon, whereas, with less
reactive a,b-unsaturated ketones and thioesters, attack on the
b position was preferred.7 Kasparyan et al. extended this work
to some homologues of PigD and suggested that thioester
3 may be the true natural product of PigD.8
In this work, we show that thioester 3 is indeed an intermediate
in the MAP biosynthetic pathway. In addition, we provide evidence
that PigE catalyses the reduction of the thioester intermediate to
aldehyde 4 as well as catalysing the transamination of that
aldehyde. As a result, we propose an alternative biosynthetic path-
way for the formation of MAP which uses 2-octenoyl thioester 2,
either with coenzyme A (CoA) or an acyl carrier protein (ACP), as its
starting point (Fig. 1).
Results and discussion
Preparation of potential substrates
CoA and ACP thioesters are common intermediates in biosynthesis.
In particular, straight-chain thioesters with even numbers of car-
bons are readily available from fatty acid biosynthesis (or degrada-
tion). In addition, it has been shown that PigD catalyses the transfer
of an acetyl group from pyruvate to N-acetylcysteamine (NAC)
thioester 12 to give thioester 13 (Fig. 2).7,8 Considering that NAC
thioesters mimic CoA or ACP thioesters, we synthesised 13 to
investigate if it could be converted to prodigiosin by S39006.
As thioesters are prone to hydrolysis and all testing of 13
would be done in aqueous solution, its hydrolysis product,
3-acetyloctanoic acid 14, was also synthesised, as a negative
control, and the known PigE substrate 3-acetyloctanal 4 was
synthesised as the positive control.
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Acid 14 was obtained in three steps from 2-octanone (see ESI†):
bromination on C-3 was followed by displacement of bromide
by dimethyl malonate and then hydrolysis/decarboxylation.
Acid 14 was then converted to 13 via thioesterification with
N-acetylcysteamine. Aldehyde 4 was obtained by reduction of 14
to the diol 15 followed by Swern oxidation.
Chemical complementation assays
S39006 DpigD has an in-frame deletion in pigD, avoiding any
downstream polarity in the prodigiosin biosynthetic operon,
and presents a white phenotype.3 However, when fed with an
intermediate accepted by one of the subsequent enzymes in the
MAP biosynthetic pathway this strain produces 11 and there-
fore presents a red phenotype.3,6
In a qualitative assay, S39006 DpigD was streaked on agar
plates and spots (2 ml, 1 M) of aldehyde 4 and thioester 13 were
placed next to the streaks. After 12 h, a red colour was visible in
the streak next to the spot in both cases (Fig. 3), suggesting that
both compounds could restore prodigiosin production. The
colour was less intense in the case of the thioester, perhaps
suggesting less efficient uptake into the cell or less efficient
utilisation of the NAC thioester than the true thioester
intermediate.
These results were confirmed by a quantitative complemen-
tation assay in liquid culture. After optimisation to overcome
low levels of production of 11 due to the toxicity of 4, S39006
DpigD was treated with 4, 13 or 14 (1 mM) for 16 h and
prodigiosin was then extracted from cell pellets with acidified
EtOH and quantified by its absorbance at 535 nm.9 Again the
results (Fig. 4) were that pigmentation was observed with
aldehyde 4 and thioester 13 but not with carboxylic acid 14.
The UV spectrum of the extract of the culture treated with 13
showed a maximum at 535 nm (Fig. 4c), consistent with
prodigiosin.
Extracts from cultures of S39006 DpigD not treated with any
substrate have some absorption at 535 nm but this is a sloping
baseline and no peak is seen. Nevertheless, to confirm that the
increase in absorbance during the chemical complementation
experiments was due to prodigiosin and not some other
Fig. 1 Biosynthesis of prodigiosin; green; formation of MAP, blue: formation of MBC, red: condensation. HBM is 4-hydroxy-2,2 0-bipyrrole-5-methanol
and HBC is 4-hydroxy-2,2 0-bipyrrole-5-carbaldehyde.
Fig. 2 Syntheses of potential substrates of PigE.
Fig. 3 Chemical complementation of S39006 DpigD with aldehyde 4 (left)
and thioester 13 (right).
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metabolite, an ethanolic extract from a culture of wild-type
S39006 was analysed by HPLC. Two peaks absorbing at 535 nm
were observed and LCMS (see ESI†) showed they were prodigiosin
11 and norprodigiosin 10. Norprodigiosin results from the con-
densation of the unmethylated bipyrrole HBC 8 with MAP 7 (see
Fig. 1). The peaks corresponding to 11 and 10 were also observed
in the HPLC trace of the extract from S39006 DPigD treated with
13 (Fig. 4d). This proves that thioester 13 can restore production
of prodigiosin in S39006 DpigD. Thus it is very likely that a related
thioester is an intermediate in the biosynthesis of MAP.
Bioinformatic analysis of PigE
The presence of a thioester intermediate in MAP biosynthesis
implies that a reduction step converting the thioester to an
aldehyde needs to be added to the original pathway. The
possibility that PigE had thioester reductase activity as well as
the established aminotransferase activity was investigated.
The sequence of PigE was analysed using the NCBI BLAST
software.10 This showed that the C-terminal region of PigE
(residues 394 to 848) had strong similarity with pyridoxal
phosphate (PLP)-dependent aminotransferases, particularly
class III aminotransferases that generally act on or produce
terminal alkylamines.11 A crystal structure of the C-terminal
domain with PLP bound has been published.5 The N-terminal
region (residues 2 to 341) showed homology with acyl-ACP
reductases, which catalyse the reduction of fatty acyl ACP thioesters
to the corresponding aldehydes.12 The majority of proteins that
showed good similarity with full length PigE were homologues in
other organisms known to produce prodigiosin or related com-
pounds (e.g. TamH in tambjamine biosynthesis13).
PHYRE2 homology modelling software14 generated a struc-
tural model for the N-terminal domain (see ESI†) using the
recently published structure of the acyl-ACP reductase (AAR)
involved in cyanobacterial biosynthesis of hydrocarbons (26%
identity).15 The second best hit was glutamyl tRNA reductase
(GluTR) from Methanopyrus kandleri (17% identity), which
catalyses the transformation of glutamyl tRNA into glutamate-
1-semialdehyde, the first committed step of heme biosynthesis
in plants, algae and most bacteria. Both these enzymes initially
transfer the acyl group onto an active site cysteine residue and
it is this thioester intermediate that is subsequently reduced by
NADPH.16 This cysteine residue is conserved in PigE (Cys296)
and is in the same position in the homology model as Cys294 in
AAR when the two structures are overlaid. Interestingly both
AAR and GluTR have been shown to channel their product
aldehydes directly to the next enzyme in the pathway via an exit
tunnel that is distinct from the substrate entry route. For AAR
the next enzyme is a di-iron-dependent aldehyde-deformylating
oxygenase (ADO),15 but for GluTR it is a PLP-dependent amino-
transferase, glutamate-1-semialdehyde aminomutase (GSAM).17
It seems likely, therefore, that the reductase and aminotransferase
domains of PigE form a structure similar to the GluTR-GSAM
complex and substrate channelling of aldehyde 4 may occur.
The bioinformatic analysis, therefore, reveals the presence of
two domains in PigE: a C-terminal aminotransferase domain,
and a N-terminal thioester reductase domain. This strongly
suggests that the N-terminal domain of PigE is the protein that
catalyses the reduction of the thioester intermediate.
In vitro characterisation of PigE
Plasmid pQE80-L::oriT containing pigE from S39006 was trans-
formed into E. coli BL21, giving strain E. coli pPigE. PigE
protein was purified from cultures of this strain. A UV spectrum
of the purified PigE showed a peak at 410 nm, consistent with
PLP bound as its Schiff’s base with the active-site lysine residue.
(Fig. 5).
To determine the likely amino donor in the transaminase
reaction PigE was incubated with various amino acids individually
and the formation of the pyridoxamine phosphate (PMP) inter-
mediate was monitored by recording the absorbance at 330 nm.
The most significant increase was observed with ornithine and
Fig. 4 Results of the quantitative chemical complementation assays;
(a) ethanolic extract of cultures of S39006 WT and S39006 DpigD
incubated with no additive (f), aldehyde 4, carboxylic acid 14 or thioester
13; (b) Absorbance at 535 nm normalised by OD600 for the specified
extracts; (c) UV spectrum of the extract of S39006 DpigD inoculated with
thioester 13; (d) Comparison of the HPLC traces (535 nm) of the extracts of
S39006 WT and S39006 DpigD incubated with thioester 13.
Fig. 5 (a) Intermediates in PLP-catalysed transamination; (b) UV spectra
of isolated PigE; (c) change in the A330 of PigE after 24 h in the presence of
various amino acids.
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arginine (Fig. 5c) suggesting that PigE is a transaminase dependent
on these amino acids.
Lysates prepared from E. coli BL21 and E. coli pPigE were
supplemented with thioester 13, ornithine and PLP and incubated
at 30 1C for 16 h. After removing cell debris, the resulting mixtures
were analysed by LCMS and compared with synthetic samples of
H2MAP 6 and thioester 13 (Fig. 6). In the extract from E. coli BL21,
only the peak corresponding to the thioester 13 was visible. In the
extract from E. coli pPigE, the main peak corresponded to H2MAP
6 and only a very small peak corresponding to 13 was visible. This
is a strong indication that the presence of PigE was necessary for
13 to be reduced in addition to the transamination to give 6.
When purified PigE was incubated with thioester 13, ornithine
and NAD(P)H at 30 1C for 16 h in phosphate buffer, no peak
corresponding to H2MAP could be detected by LCMS. Similarly
experiments with the same substrates in the presence of a variety of
metal ions failed to show any significant change in absorbance of
NAD(P)H at 340 nm over time resulting from the presence of PigE.
Taken together these experiments suggest that additional cofactors
and/or metal ions contained in the cell lysates may be necessary for
rapid reaction to occur. It is noteworthy that the activity of GluTR, to
which the N-terminal domain of PigE may be related, is affected by
several regulatory proteins and by the presence of the tRNA18 and
activity can easily be lost by oxidation of the active site cysteine.16
Conclusions
We have shown that thioester 13 can restore production of
prodigiosin in the deficient strain, S39006 DpigD. In the presence
of PigE, the thioester can be reduced, and the resulting aldehyde
undergoes transamination, leading to the next biosynthetic
intermediate, H2MAP.
We therefore propose the revised biosynthetic pathway for
prodigiosin shown in Fig. 1. Our results, along with the
bioinformatic analysis, support the notion that PigE is a
bifunctional enzyme, with a thioester reductase domain in its
N-terminal region and a transaminase domain in its C-terminal
region. We also propose that the amino donor for the trans-
aminase activity is mostly likely ornithine or arginine.
Experimental
Prodigiosin production and quantification
Prodigiosin production from S30096 WT. Luria-Bertani broth
(LB: tryptone 10 g L1, yeast extract 5 g L1, NaCl 10 g L1)
supplemented with 0.25 M sorbitol was inoculated with an
overnight culture of the strain. The culture was incubated at
30 1C, with shaking at 250 rpm for 16 h. 25 ml of cells were then
pelleted (2219 g, 20 min, 4 1C) and the supernatant was dis-
carded. The pellets were vortexed for 1 min in 5 ml of acidified
EtOH (4% 1 M HCl). After centrifugation the supernatant gave
the desired prodiginine extract.
Prodigiosin production from S39006 DpigD. The strain was
grown in LB supplemented with 0.25 M sorbitol at 30 1C, with
shaking at 250 rpm until the OD600 reached 4. Then 4, 13 or 14
(1 mM final concentration) was added and the incubation
extended for a further 16 h. Cells were then pelleted and
prodiginine extracted as described above.
Prodigiosin quantification. A direct measurement of the
absorbance at 535 nm was performed on a Cary 300-Bio
UV-visible spectrophotometer.
Cell extract assays
E. coli BL21 or E. coli pPigE were cultured in 200 ml of LB until
and OD600 = 0.6. Cultures were then induced with 1 mM IPTG at
16 1C for 14–16 h. Cells were harvested by centrifugation at
4500 rpm for 20 min at 4 1C. The cells were held on ice for
15 min and then resuspended in 20 ml of phosphate buffer.
After a further 30 min on ice, the cell suspensions were
sonicated (6  20 s with 30 s breaks). Eppendorf tubes were
charged with 13 (1 mM), and ornithine and PLP (1.25 mM final
concentrations), then cell lysate was added to a total volume of
0.5 ml. The resulting mixture was gently shaken overnight at
30 1C, then centrifuged and the supernatant was analysed
directly by LCMS.
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